REFERENCES
Abe M, Hasegawa K, Wada H, Morimoto T, Yanazume T, Kawamura T, . . .
Kita T (2003). GATA-6 is involved in PPARgamma-mediated activation of
differentiated phenotype in human vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol 23: 404-410.
Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, &
Cohen RA (2004). S-Glutathiolation by peroxynitrite activates SERCA
during arterial relaxation by nitric oxide. Nat Med 10:1200-1207.
Ailawadi G, Moehle CW, Pei H, Walton SP, Yang Z, Kron IL, . . . Owens GK
(2009). Smooth muscle phenotypic modulation is an early event in aortic
aneurysms. J Thorac Cardiovasc Surg 138: 1392-1399.
Alexander SPH, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, . .
. Collaborators C (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20:
Introduction and Other Protein Targets. Br J Pharmacol 176 Suppl
1: S1-S20.
Bhamidipati CM, Whatling CA, Mehta GS, Meher AK, Hajzus VA, Su G, . . .
Ailawadi G (2014). 5-Lipoxygenase pathway in experimental abdominal
aortic aneurysms. Arterioscler Thromb Vasc Biol 34: 2669-2678.
Blanquart C, Barbier O, Fruchart JC, Staels B, & Glineur C (2003).
Peroxisome proliferator-activated receptors: regulation of
transcriptional activities and roles in inflammation. J Steroid Biochem
Mol Biol 85: 267-273.
Chen R, Yan J, Liu P, & Wang Z (2015). Effects of thiazolidinedione
therapy on inflammatory markers of type 2 diabetes: a meta-analysis of
randomized controlled trials. PLoS One 10: e0123703.
Cornea RL, Gruber SJ, Lockamy EL, Muretta JM, Jin D, Chen J, . . .
Thomas DD (2013). High-throughput FRET assay yields allosteric SERCA
activators. Journal of biomolecular screening 18: 97-107.
Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SP, Giembycz MA, . .
. McGrath JC (2015). Experimental design and analysis and their
reporting: new guidance for publication in BJP. Br J Pharmacol
172: 3461-3471.
de Winther MP, Kanters E, Kraal G, & Hofker MH (2005). Nuclear factor
kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol
25: 904-914.
Golledge J, Cullen B, Rush C, Moran CS, Secomb E, Wood F, . . . Norman
PE (2010). Peroxisome proliferator-activated receptor ligands reduce
aortic dilatation in a mouse model of aortic aneurysm. Atherosclerosis
210: 51-56.
Golledge J, Muller J, Shephard N, Clancy P, Smallwood L, Moran C, . . .
Norman PE (2007). Association between osteopontin and human abdominal
aortic aneurysm. Arterioscler Thromb Vasc Biol 27: 655-660.
Halabi CM, Beyer AM, de Lange WJ, Keen HL, Baumbach GL, Faraci FM, &
Sigmund CD (2008). Interference with PPAR gamma function in smooth
muscle causes vascular dysfunction and hypertension. Cell Metab
7: 215-226.
Hamblin M, Chang L, Fan Y, Zhang J, & and Chen Y (2009). PPARs and the
cardiovascular system. Antioxid Redox Signal 11: 1415-1452.
Harding SD, Sharman JL, Faccenda E, Southan C, Pawson AJ, Ireland S, . .
. Nc I (2018). The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and
expansion to encompass the new guide to IMMUNOPHARMACOLOGY. Nucleic
Acids Res 46: D1091-D1106.
Hasan DM, Starke RM, Gu H, Wilson K, Chu Y, Chalouhi N, . . . Sigmund CD
(2015). Smooth Muscle Peroxisome Proliferator-Activated Receptor gamma
Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in
Mice In Vivo. Hypertension 66: 211-220.
Hu Q, Zhang XJ, Zhang C, Zhao YX, He H, Liu CX, . . . Zhang Y (2008).
Peroxisome proliferator-activated receptor-gamma1 gene therapy
attenuates atherosclerosis and stabilizes plaques in apolipoprotein
E-deficient mice. Hum Gene Ther 19: 287-299.
Kim HB, Kumar A, Wang L, Liu GH, Keller SR, Lawrence JC, Jr., . . .
Harris TE (2010). Lipin 1 represses NFATc4 transcriptional activity in
adipocytes to inhibit secretion of inflammatory factors. Mol Cell Biol
30: 3126-3139.
Li Y, Zhu J, & Ding JQ (2015). Association of the PPARgamma2 Pro12Ala
polymorphism with increased risk of cardiovascular diseases. Genet Mol
Res 14: 18662-18674.
Limor R, Sharon O, Knoll E, Many A, Weisinger G, & Stern N (2008).
Lipoxygenase-derived metabolites are regulators of peroxisome
proliferator-activated receptor gamma-2 expression in human vascular
smooth muscle cells. Am J Hypertens 21: 219-223.
Liu G, Wu F, Jiang X, Que Y, Qin Z, Hu P, . . . Tong X (2020).
Inactivation of Cys(674) in SERCA2 increases BP by inducing endoplasmic
reticulum stress and soluble epoxide hydrolase. Br J Pharmacol
177: 1793-1805.
Liu L, & Clipstone NA (2007). Prostaglandin F2alpha inhibits adipocyte
differentiation via a G alpha q-calcium-calcineurin-dependent signaling
pathway. J Cell Biochem 100: 161-173.
Meng YH, Tian C, Liu L, Wang L, & Chang Q (2014). Elevated expression
of connective tissue growth factor, osteopontin and increased collagen
content in human ascending thoracic aortic aneurysms. Vascular
22: 20-27.
Meredith D, Panchatcharam M, Miriyala S, Tsai YS, Morris AJ, Maeda N, .
. . Smyth SS (2009). Dominant-negative loss of PPARgamma function
enhances smooth muscle cell proliferation, migration, and vascular
remodeling. Arterioscler Thromb Vasc Biol 29: 465-471.
Miyake T, Aoki M, Masaki H, Kawasaki T, Oishi M, Kataoka K, . . .
Morishita R (2007). Regression of abdominal aortic aneurysms by
simultaneous inhibition of nuclear factor kappaB and ets in a rabbit
model. Circ Res 101: 1175-1184.
Monaco C, & Paleolog E (2004). Nuclear factor kappaB: a potential
therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res
61: 671-682.
Motoki T, Kurobe H, Hirata Y, Nakayama T, Kinoshita H, Rocco KA, . . .
Kitagawa T (2015). PPAR-gamma agonist attenuates inflammation in aortic
aneurysm patients. Gen Thorac Cardiovasc Surg 63: 565-571.
Mukohda M, Lu KT, Guo DF, Wu J, Keen HL, Liu X, . . . Sigmund CD (2017).
Hypertension-Causing Mutation in Peroxisome Proliferator-Activated
Receptor gamma Impairs Nuclear Export of Nuclear Factor-kappaB p65 in
Vascular Smooth Muscle. Hypertension 70: 174-182.
Nakao T, Horie T, Baba O, Nishiga M, Nishino T, Izuhara M, . . . Ono K
(2017). Genetic Ablation of MicroRNA-33 Attenuates Inflammation and
Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory
Pathways. Arterioscler Thromb Vasc Biol 37: 2161-2170.
Nieves-Cintron M, Amberg GC, Nichols CB, Molkentin JD, & Santana LF
(2007). Activation of NFATc3 down-regulates the beta1 subunit of large
conductance, calcium-activated K+ channels in arterial smooth muscle and
contributes to hypertension. J Biol Chem 282: 3231-3240.
Qin F, Siwik DA, Lancel S, Zhang J, Kuster GM, Luptak I, . . . Colucci
WS (2013). Hydrogen peroxide-mediated SERCA cysteine 674 oxidation
contributes to impaired cardiac myocyte relaxation in senescent mouse
heart. J Am Heart Assoc 2: e000184.
Que Y, Shu X, Wang L, Hu P, Wang S, Xiong R, . . . Tong X (2020).
Inactivation of cysteine 674 in the SERCA2 accelerates experimental
aortic aneurysm. J Mol Cell Cardiol.
Serfling E, Berberich-Siebelt F, Avots A, Chuvpilo S, Klein-Hessling S,
Jha MK, . . . Palmetshofer A (2004). NFAT and NF-kappaB factors-the
distant relatives. Int J Biochem Cell Biol 36: 1166-1170.
Shimada K, Furukawa H, Wada K, Korai M, Wei Y, Tada Y, . . . Hashimoto T
(2015). Protective Role of Peroxisome Proliferator-Activated
Receptor-gamma in the Development of Intracranial Aneurysm Rupture.
Stroke 46: 1664-1672.
Subramanian V, Golledge J, Heywood EB, Bruemmer D, & Daugherty A
(2012). Regulation of peroxisome proliferator-activated receptor-gamma
by angiotensin II via transforming growth factor-beta1-activated p38
mitogen-activated protein kinase in aortic smooth muscle cells.
Arterioscler Thromb Vasc Biol 32: 397-405.
Tang RH, Zheng XL, Callis TE, Stansfield WE, He J, Baldwin AS, . . .
Selzman CH (2008). Myocardin inhibits cellular proliferation by
inhibiting NF-kappaB(p65)-dependent cell cycle progression. Proc Natl
Acad Sci U S A 105: 3362-3367.
Thompson MD, Mei Y, Weisbrod RM, Silver M, Shukla PC, Bolotina VM, . . .
Tong X (2014). Glutathione adducts on sarcoplasmic/endoplasmic reticulum
Ca2+ ATPase Cys-674 regulate endothelial cell calcium stores and
angiogenic function as well as promote ischemic blood flow recovery. J
Biol Chem 289: 19907-19916.
Tong X, Khandelwal AR, Qin Z, Wu X, Chen L, Ago T, . . . Cohen RA
(2015). Role of smooth muscle Nox4-based NADPH oxidase in neointimal
hyperplasia. J Mol Cell Cardiol 89: 185-194.
Tong X, Khandelwal AR, Wu X, Xu Z, Yu W, Chen C, . . . Zeng C (2016).
Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase. J Mol
Cell Cardiol 92: 30-40.
Tong X, Ying J, Pimentel DR, Trucillo M, Adachi T, & Cohen RA (2008).
High glucose oxidizes SERCA cysteine-674 and prevents inhibition by
nitric oxide of smooth muscle cell migration. J Mol Cell Cardiol
44: 361-369.
Tsai MH, Lee CW, Hsu LF, Li SY, Chiang YC, Lee MH, . . . Lee IT (2017).
CO-releasing molecules CORM2 attenuates angiotensin II-induced human
aortic smooth muscle cell migration through inhibition of ROS/IL-6
generation and matrix metalloproteinases-9 expression. Redox Biol
12: 377-388.
Wang L, Zhang J, Fu W, Guo D, Jiang J, & Wang Y (2012a). Association of
smooth muscle cell phenotypes with extracellular matrix disorders in
thoracic aortic dissection. J Vasc Surg 56: 1698-1709, 1709
e1691.
Wang S, Zhang C, Zhang M, Liang B, Zhu H, Lee J, . . . Zou MH (2012b).
Activation of AMP-activated protein kinase alpha2 by nicotine instigates
formation of abdominal aortic aneurysms in mice in vivo. Nat Med
18: 902-910.
Werman A, Hollenberg A, Solanes G, Bjorbaek C, Vidal-Puig AJ, & Flier
JS (1997). Ligand-independent activation domain in the N terminus of
peroxisome proliferator-activated receptor gamma (PPARgamma).
Differential activity of PPARgamma1 and -2 isoforms and influence of
insulin. J Biol Chem 272: 20230-20235.
Xie X, Li S, Zhu Y, Liu L, Pan Y, Wang J, . . . Li M (2017).
MicroRNA-27a/b mediates endothelin-1-induced PPARgamma reduction and
proliferation of pulmonary artery smooth muscle cells. Cell Tissue Res
369: 527-539.
Yang TT, & Chow CW (2003). Transcription cooperation by NFAT.C/EBP
composite enhancer complex. J Biol Chem 278: 15874-15885.
Yang XY, Wang LH, Chen T, Hodge DR, Resau JH, DaSilva L, & Farrar WL
(2000). Activation of human T lymphocytes is inhibited by peroxisome
proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma
co-association with transcription factor NFAT. J Biol Chem 275:4541-4544.
Ying J, Sharov V, Xu S, Jiang B, Gerrity R, Schoneich C, & Cohen RA
(2008). Cysteine-674 oxidation and degradation of sarcoplasmic reticulum
Ca(2+) ATPase in diabetic pig aorta. Free Radic Biol Med 45:756-762.